Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Comment
Nick Dearden

With monkeypox, profits are once again being put ahead of protecting life

A monkeypox vaccination sign, Miami Beach, Florida.
‘Comparisons have been drawn between the monkeypox outbreak and Covid-19. While the disease is very different, access to vaccines is just as unequal.’ Photograph: Lynne Sladky/AP

Two weeks ago I queued for more than five hours outside a London hospital to receive a monkeypox vaccination. But I’m one of the lucky ones; thousands of people in at-risk groups haven’t been so fortunate, and it’s about to get worse. Britain, despite being one of the centres of the outbreak, expects to run out of vaccines in the next couple of weeks, with no further deliveries planned until late September.

This matters because it’s a race against time to prevent monkeypox becoming an endemic disease. At that point, we’ll be stuck with it, and it will continue to circulate at low levels indefinitely, with regular danger of outbreaks and possibly new and more dangerous variants. Even in the optimistic scenario that it gets no more severe, lives will be lost. And while LGBTQ+ groups have led the way in demanding a stronger response, we know that the disease is particularly dangerous for several groups, including small children, pregnant women and those with compromised immune systems.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.